FAIL (the browser should render some flash content, not this).

The New Concept of Benchtop Sequencing

IBS has developed a new type of benchtop sequencing system that is capable of performing up to 20 independent sequencing runs in parallel and allows random loading of the flow cells at any time during a run. The new system is just about to enter early beta testing.

The IBS Team.                             TEAM

Intelligent Bio-Systems is a group of innovative and experienced chemists, molecular biologists and engineers capable of bringing breakthrough technologies to market quickly.
Click here for a list of open positions at the company.

About Us

Intelligent Bio-Systems was founded in 2005 by Drs. Steven J. Gordon and Jingyue Ju to commercialize an advanced DNA sequencing system. Dr. Gordon previously founded Intelligent Automation Systems, which was responsible for a number of key instrumentation solutions which helped to complete the Human Genome Project. Dr. Ju is one of the key inventors of fluorescent energy transfer dyes used in most electrophoresis-based sequencers.

Key Aspects of the IBS
 Sequencing Technology

  • Parallel data generation
  • Chip-based technology
  • Early patent protection
  • Proprietary chemistry
  • Innovative sample prep
  • Low cost consumables
  • Low cost instrument
  • High precision data
  • Precise homopolymer data
  • Fast cycle time
  • Affordable for most labs
  • Designed for clinical use

Click Here for more details

Licensing Partner
Intelligent Bio-Systems is the exclusive licensee of Columbia University's sequencing by synthesis patent portfolio invented by Dr. Jingyue Ju

Click here for a description of the technology.